(Q41165180)

27 September 2017

1 reference

title

Outcome of silent lupus nephritis (English)

1 reference

27 September 2017

Gonzalez-Crespo MR

1

1 reference

27 September 2017

Lopez-Fernandez JI

2

1 reference

27 September 2017

Usera G

3

1 reference

27 September 2017

Poveda MJ

4

1 reference

27 September 2017

Gomez-Reino JJ

5

1 reference

27 September 2017

1 August 1996

1 reference

Seminars in Arthritis and Rheumatism

27 September 2017

1 reference

27 September 2017

26

1 reference

27 September 2017

1

1 reference

27 September 2017

468-476

1 reference

Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease

27 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Acute and subacute disseminated lupus erythematosus; a correlation of clinical and postmortem findings in eighteen cases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Renal involvement in systemic lupud erythematosus (SLE): a study of 56 patients emphasizing histologic classification

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Renal histology and clinical course of systemic lupus erythematosus. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Systemic lupus erythematosus without clinical renal abnormalities: renal biopsy findings and clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Systemic lupus erythematosus within the first two decades of life

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Natural history of "silent" lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

The prognosis of lupus nephritis. Role of clinical-pathologic correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Prognostic indices in lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Renal biopsies in lupus nephritis. Correlation of electron microscopic findings with clinical course.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Light, immunofluorescence and electron microscopy renal biopsy findings as predictors of mortality in eighty-five Spanish patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Kidney biopsy in systemic lupus erythematosus. II. Survival analyses according to biopsy results

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Kidney biopsy in systemic lupus erythematosus. III. Survival analysis controlling for clinical and laboratory variables

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Clinically occult diffuse proliferative lupus nephritis. An age-related phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

RENAL DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

The distribution and character of glomerular deposits in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

THE SPECTRUM OF LUPUS NEPHRITIS

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. Lupus Nephritis Collaborative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Role of pathology indices in the management of severe lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Marginal benefit of renal biopsy in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Recognition of information in renal biopsies of patients with lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

The information content from renal biopsy in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Lupus nephritis. Experience with 230 patients in a private practice from 1950 to 1980

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

The pathogenesis and prognosis of lupus nephritis: information from repeat renal biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

The value of the renal biopsy in lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Prognostic factors in lupus nephritis. Contribution of renal histologic data

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

The clinical course of the proliferative and membranous forms of lupus nephritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Treatment of Diffuse Proliferative Lupus Nephritis with Prednisone and Combined Prednisone and Cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Controlled studies of oral immunosuppressive drugs in lupus nephritis. A long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Systemic lupus erythematosus--survival patterns. Experience with 609 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Lupus nephropathy without clinical renal involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

Ultrastructural lesions in kidneys with minimal involvement by systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980027-8

7 January 2021

10.1016/S0049-0172(96)80027-8

Identifiers

DOI

1 reference

27 September 2017

1 reference